Related Experiment Videos
Bradykinin receptor ligands: therapeutic perspectives
François Marceau1, Domenico Regoli
1Centre de Recherche, Centre Hospitalier Universitaire de Québec, Pavillon L'Hôtel-Dieu de Québec, 11 Côte-du-Palais,Québec, Canada G1R 2J6. francois.marceau@crhdq.ulaval.ca
Nature Reviews. Drug Discovery
|October 2, 2004
Summary
This review explores recent advancements in understanding kinins and bradykinin receptors. Developments in medicinal chemistry are bringing therapeutic applications of kinin receptor ligands closer.
Area of Science:
- Biochemistry
- Pharmacology
- Physiology
Background:
- Kinins are peptides produced by kallikrein enzymes, acting locally via G-protein-coupled bradykinin receptors.
- The kallikrein-kinin system regulates circulation, kidney function, inflammation, and pain.
- Modulators of bradykinin receptors are of therapeutic interest.
Purpose of the Study:
- To review recent progress in the genetics, molecular biology, and pathophysiology of kinins and their receptors.
- To discuss developments in medicinal chemistry for therapeutic applications.
- To highlight the potential of kinin receptor antagonists as non-addictive analgesics.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of genetic, molecular, and pathophysiological data.
- Examination of medicinal chemistry advancements in kinin receptor ligand development.
Main Results:
- Significant progress has been made in understanding kinin and bradykinin receptor biology.
- Medicinal chemistry efforts have advanced the development of kinin receptor ligands.
- Kinin receptor antagonists show promise as novel analgesics with low abuse potential.
Conclusions:
- Recent research has significantly advanced the understanding of the kallikrein-kinin system.
- Therapeutic applications of kinin receptor ligands are becoming more attainable.
- Kinin receptor antagonists represent a promising avenue for developing safer pain management strategies.